Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

The Market Online’s Weekly Cannabis Report – July 26, 2024

Jonathon Brown Jonathon Brown, The Market Online
0 Comments| July 26, 2024

{{labelSign}}  Favorites
{{errorMessage}}

Tilray Medical has been approved for a new medical cannabis extract in Portugal. The extract, Tilray Oral Solution THC10:CBD10, also known as Tilray Solução Oral THC10:CBD10, is now approved for medical use. This follows the approval of Tilray Medical whole flower THC 18, and approval for the first cannabis extract in Portugal earlier this year.

Click here for the full story.

Click to enlarge
Source: Tilray.

Weekly Update – Top Cannabis News Stories

1 | Top Story: Herbal Dispatch announces record revenue, positive net income

2 | Curaleaf announces New York retail expansion, two new medical dispensaries and sales at existing stores

3 | Beboe elevates New York’s cannabis scene, socially dosed edible and vape products

Click to enlarge

Top Cannabis Stocks July 19 to July 25, 2024

1. T.TLRY | 7,656 views | .Tilray Brands Inc.
2. T.WEED | 5,274 views | Canopy Growth Corp
3.T.LABS | 4,464 views | Medipharm Labs Corp.
4. C.OILS | 2,374 views | Nextleaf Solutions Ltd.
5. C.CURA | 2,236 views | Curaleaf Holdings Inc.
6. TSX:DN | 1,121 views | Delta 9 Cannabis Inc.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

(Top photo: File)




{{labelSign}}  Favorites
{{errorMessage}}